Horizon Investments’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $863K | Buy |
4,428
+59
| +1% | +$12.2K | 0.01% | 783 |
|
|
2026
Q1 | $981K | Buy |
4,369
+85
| +2% | +$21.2K | 0.01% | 655 |
|
|
2025
Q4 | $1.03M | Sell |
4,284
-342
| -7% | -$87.5K | 0.01% | 623 |
|
|
2025
Q3 | $1.27M | Buy |
4,626
+135
| +3% | +$36.9K | 0.02% | 571 |
|
|
2025
Q2 | $1.16M | Buy |
4,491
+2,383
| +113% | +$568K | 0.02% | 531 |
|
|
2025
Q1 | $471K | Buy |
2,108
+97
| +5% | +$22.6K | 0.01% | 384 |
|
|
2024
Q4 | $460K | Buy |
2,011
+16
| +0.8% | +$3.85K | 0.01% | 384 |
|
|
2024
Q3 | $486K | Sell |
1,995
-215
| -10% | -$48K | 0.01% | 372 |
|
|
2024
Q2 | $423K | Buy |
2,210
+171
| +8% | +$34.7K | 0.01% | 396 |
|
|
2024
Q1 | $403K | Sell |
2,039
-12
| -0.6% | -$2.2K | 0.01% | 395 |
|
|
2023
Q4 | $352K | Buy |
2,051
+71
| +4% | +$10.9K | 0.01% | 394 |
|
|
2023
Q3 | $292K | Buy |
1,980
+27
| +1% | +$4.88K | 0.01% | 415 |
|
|
2023
Q2 | $427K | Buy |
1,953
+196
| +11% | +$43.7K | 0.01% | 336 |
|
|
2023
Q1 | $384K | Sell |
1,757
-665
| -27% | -$144K | 0.01% | 339 |
|
|
2022
Q4 | $503K | Buy |
2,422
+964
| +66% | +$212K | 0.01% | 371 |
|
|
2022
Q3 | $318K | Buy |
1,458
+235
| +19% | +$53.5K | 0.01% | 396 |
|
|
2022
Q2 | $256K | Sell |
1,223
-105
| -8% | -$22.4K | 0.01% | 406 |
|
|
2022
Q1 | $321K | Sell |
1,328
-482
| -27% | -$117K | 0.01% | 432 |
|
|
2021
Q4 | $471K | Buy |
1,810
+818
| +82% | +$212K | 0.01% | 336 |
|
|
2021
Q3 | $261K | Buy |
992
+40
| +4% | +$10.9K | 0.01% | 422 |
|
|
2021
Q2 | $235K | Buy |
+952
| New | +$200K | 0.01% | 427 |
|
|
2020
Q4 | – | Sell |
-3,888
| Closed | -$665K | – | 333 |
|
|
2020
Q3 | $665K | Buy |
3,888
+980
| +34% | +$181K | 0.02% | 235 |
|
|
2020
Q2 | $558K | Buy |
2,908
+1,031
| +55% | +$169K | 0.01% | 315 |
|
|
2020
Q1 | $276K | Sell |
1,877
-692
| -27% | -$110K | 0.01% | 247 |
|
|
2019
Q4 | $398K | Buy |
2,569
+289
| +13% | +$41.7K | 0.02% | 338 |
|
|
2019
Q3 | $308K | Buy |
2,280
+14
| +0.6% | +$1.83K | 0.01% | 240 |
|
|
2019
Q2 | $277K | Buy |
+2,266
| New | +$251K | 0.01% | 419 |
|
|
2018
Q4 | – | Sell |
-16,801
| Closed | -$1.94M | – | 288 |
|
|
2018
Q3 | $1.94M | Buy |
+16,801
| New | +$1.84M | 0.06% | 88 |
|
Other funds holding RMD
Horizon Investments's RMD Position: Q2 2026 in Review
Horizon Investments increased its ResMed (RMD) stake by 1.4% in Q2 2026, buying an estimated $12.2K and bringing the position to 4,428 shares worth $863K. The position accounts for 0.01% of the portfolio, ranked #783.
Horizon Investments first reported a position in RMD in Q3 2018 and has held it in 28 quarters since. The position peaked at $1.94M in Q3 2018. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Horizon Investments held 4,428 shares of ResMed worth $863K as of Q2 2026.
- Horizon Investments bought 59 ResMed shares in Q2 2026, an estimated $12.2K.
- ResMed made up 0.01% of Horizon Investments's portfolio in Q2 2026, its #783 holding.
- Horizon Investments first reported a position in ResMed in Q3 2018 and has held it in 28 quarters since.
- Horizon Investments's ResMed position peaked at $1.94M in Q3 2018.
- 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.